J.Henderson H.BioTech.F.A2/ LU2441282899 /
| NAV2024-04-29 | Chg.+0.3900 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 20.0000EUR | +1.99% | reinvestment | Equity Worldwide | Janus Henderson Inv. ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | - | - | 2.05 | -4.75 | -6.94 | 5.03 | 7.58 | 8.23 | 2.67 | 9.21 | -0.55 | -0.37 | - |
| 2023 | 0.80 | -1.59 | -0.68 | 2.82 | 6.27 | -1.20 | 0.46 | 1.85 | -0.79 | -12.22 | 8.33 | 14.23 | +17.26% |
| 2024 | 5.52 | 5.93 | -1.74 | -4.26 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 17.99% | 21.60% | 20.45% | -% | -% |
| Sharpe ratio | 0.72 | 2.88 | 0.65 | - | - |
| Best month | +14.23% | +14.23% | +14.23% | +14.23% | - |
| Worst month | -4.26% | -12.22% | -12.22% | -12.22% | - |
| Maximum loss | -10.45% | -10.45% | -16.35% | - | - |
| Outperformance | - | - | - | - | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| J.Henderson H.BioTech.F.IU2 | reinvestment | 23.4100 | +15.32% | +17.17% | |
| J.Henderson H.BioTech.F.IU2 | reinvestment | 20.1900 | +17.11% | - | |
| J.Henderson H.BioTech.F.A2 | reinvestment | 22.9800 | +14.67% | +14.79% | |
| J.Henderson H.BioTech.F.H2 | reinvestment | 23.1400 | +14.16% | +15.01% | |
| J.Henderson H.BioTech.F.A2 | reinvestment | 20.0000 | +17.03% | - | |
| J.Henderson H.BioTech.F.A2 H | reinvestment | 18.0700 | +11.61% | - | |
| J.Henderson H.BioTech.F.H2 H | reinvestment | 18.3300 | +12.59% | - |
Performance
| YTD | +5.15% | ||
|---|---|---|---|
| 6 Months | +28.62% | ||
| 1 Year | +17.03% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| Since start | +53.85% | ||
| Year | |||
| 2023 | +17.26% | ||
